Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
povidone-iodine + dexamethasone sodium phosphate + isopropyl alcohol + bupivacaine
- Development stage
- Unknown
- Lead developer
- Merck
- Modality
- Small Molecules
- Administration
- Topical, Parenteral
01
Overview
This appears to be a **nonproprietary procedural combination** of four agents rather than a distinct, verified branded drug product: povidone-iodine as a topical antiseptic, dexamethasone sodium phosphate as a corticosteroid anti-inflammatory adjunct, isopropyl alcohol as a skin antiseptic/solvent component, and bupivacaine as an amide local anesthetic for peri-procedural analgesia or anesthesia. The provided public context supports the individual components and adjacent kit-like combinations involving povidone-iodine, dexamethasone sodium phosphate, and topical spray antiseptic products, but does **not** verify a specific marketed or pipeline asset consisting of this exact four-component combination. Accordingly, this entry is best treated as a combination of known pharmaceuticals and antiseptics used around interventional or surgical procedures rather than a uniquely identifiable development candidate.
- Other names
- povidone-iodine + dexamethasone sodium phosphate + isopropyl alcohol + bupivacaine
02
Targets
NaV (Voltage-gated sodium channels)GR (Glucocorticoid receptor)NMDAR (Glutamate receptor ionotropic, NMDA)Kir (Inward-rectifier potassium channels)MR (Mineralocorticoid receptor)
Beyond the preview
Go deeper on povidone-iodine + dexamethasone sodium phosphate + isopropyl alcohol + bupivacaine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on povidone-iodine + dexamethasone sodium phosphate + isopropyl alcohol + bupivacaine.